Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Genital Neoplasms, Male × rucaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Genitourinary 1

Conditions

Fallopian Tube Neoplasms 5 Ovarian Neoplasms 4 Carcinoma, Ovarian Epithelial 3 Neoplasms 2 Recurrence 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Metastatic Castration Resistant Prostate Cancer 1 Genital Neoplasms, Male 1 Adenocarcinoma, Clear Cell 1

Interventions

padeliporfin 3 rucaparib 1 palladium-bacteriopheophorbide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04676334 2024-05-07

CATCH-R

pharmaand GmbH

Phase 3 Completed

34 enrolled 9 charts

GenitourinaryGynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Genital Neoplasms, Male, Ovarian Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡